VanEck Associates
BSX.PRA

VanEck Associates’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

VanEck Associates’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$21.8M Buy
2022
Q4 		$18.2M Buy
2022
Q3 		$15.9M Buy
2022
Q2 		$13.6M Buy
2022
Q1 		$13.3M Sell
2021
Q4 		$13.8M Buy
2020
Q4 		– Sell
2020
Q3 		$10.6M Buy